Literature DB >> 19495805

T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.

Carlos Araya1, Leila Diaz, Clive Wasserfall, Mark Atkinson, Wei Mu, Richard Johnson, Eduardo Garin.   

Abstract

The purpose of this study was to test the hypothesis that, in idiopathic minimal lesion nephrotic syndrome (IMLNS), the T regulatory (T reg) cell suppressor mechanism is deficient, thereby enhancing cytokine release by T effector cells. Twenty-one patients with IMLNS, eight healthy controls and two patients with nephrotic syndrome and membranoproliferative glomerulonephritis were studied. The percentage of T reg cells was similar in the healthy controls and in patients with IMLNS in relapse or in remission. Thymidine incorporation in autologous T effector cells, as well as expression of the regulatory cytokine interleukin (IL)-10, was significantly reduced in patients in relapse when compared with patients in remission and healthy subjects. IL-2 expression was also reduced in patients in relapse but did not achieve statistical significance. In a different set of experiments, T cells, from subjects with IMLNS in remission, when stimulated with antiCD3-antiCD28 antibodies, secreted increased levels of cytokines. No such increase in cytokines was observed when cells from healthy controls were stimulated with same mitogen. The impaired T reg cell function observed in these patients may have pathogenic and therapeutic implications, because it could explain the persistence of the proposed pathogenic cytokines observed in the patients with IMLNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495805      PMCID: PMC2785122          DOI: 10.1007/s00467-009-1214-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  When ligand becomes receptor--tolerance via B7 signaling on DCs.

Authors:  Erik B Finger; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

2.  Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease.

Authors:  M K Oaks; K M Hallett
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  T-lymphocyte populations and cytokines in childhood nephrotic syndrome.

Authors:  Giuliana Lama; Ilaria Luongo; Giuseppina Tirino; Adriana Borriello; Ciro Carangio; Maria Esposito Salsano
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

5.  B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].

Authors:  Patricia A Taylor; Christopher J Lees; Sylvie Fournier; James P Allison; Arlene H Sharpe; Bruce R Blazar
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability.

Authors:  Paul F Laflam; Soichi Haraguchi; Eduardo H Garin
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

7.  Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome.

Authors:  M J Kemper; T Meyer-Jark; M Lilova; D E Müller-Wiefel
Journal:  Clin Nephrol       Date:  2003-10       Impact factor: 0.975

Review 8.  The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2).

Authors:  Ruth Y Lan; Carlos Selmi; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-04-28       Impact factor: 7.094

9.  In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Authors:  Franck J Barrat; Daniel J Cua; André Boonstra; David F Richards; Chad Crain; Huub F Savelkoul; René de Waal-Malefyt; Robert L Coffman; Catherine M Hawrylowicz; Anne O'Garra
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms.

Authors:  Kevin J Maloy; Laurence Salaun; Rachel Cahill; Gordon Dougan; Nigel J Saunders; Fiona Powrie
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

View more
  51 in total

Review 1.  The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.

Authors:  Wagner de Fátima Pereira; Gustavo Eustáquio Alvim Brito-Melo; Fábio Tadeu Lourenço Guimarães; Thiago Guimarães Rosa Carvalho; Elvis Cueva Mateo; Ana Cristina Simões e Silva
Journal:  Inflamm Res       Date:  2014-01       Impact factor: 4.575

2.  Serum levels of interleukin 10 (IL-10) in patients with type 2 diabetes.

Authors:  N Yaghini; M Mahmoodi; Gh R Asadikaram; Gh H Hassanshahi; H Khoramdelazad; M Kazemi Arababadi
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

Review 3.  Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes.

Authors:  Kazunari Kaneko; Shoji Tsuji; Takahisa Kimata; Tetsuya Kitao; Sohsaku Yamanouchi; Shogo Kato
Journal:  World J Pediatr       Date:  2015-01-28       Impact factor: 2.764

4.  Minimal change disease: a "two-hit" podocyte immune disorder?

Authors:  Michiko Shimada; Carlos Araya; Chris Rivard; Takuji Ishimoto; Richard J Johnson; Eduardo H Garin
Journal:  Pediatr Nephrol       Date:  2010-10-30       Impact factor: 3.714

Review 5.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

6.  Association of nephrotic syndrome with immune reconstitution inflammatory syndrome.

Authors:  Petra Lankisch; Hans-Jürgen Laws; Anne-Margret Wingen; Arndt Borkhardt; Tim Niehues; Jennifer Neubert
Journal:  Pediatr Nephrol       Date:  2011-12-29       Impact factor: 3.714

Review 7.  Regulatory T cells and minimal change nephropathy: in the midst of a complex network.

Authors:  R Bertelli; A Bonanni; A Di Donato; M Cioni; P Ravani; G M Ghiggeri
Journal:  Clin Exp Immunol       Date:  2015-10-12       Impact factor: 4.330

Review 8.  Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives.

Authors:  Valéry Elie; May Fakhoury; Georges Deschênes; Evelyne Jacqz-Aigrain
Journal:  Pediatr Nephrol       Date:  2011-06-28       Impact factor: 3.714

Review 9.  Childhood nephrotic syndrome--current and future therapies.

Authors:  Larry A Greenbaum; Rainer Benndorf; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2012-06-12       Impact factor: 28.314

Review 10.  Rituximab therapy in nephrotic syndrome: implications for patients' management.

Authors:  Aditi Sinha; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.